811 related articles for article (PubMed ID: 30380700)
1. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
2. Aquaporins in secretory glands and their role in Sjögren's syndrome.
Delporte C
Handb Exp Pharmacol; 2009; (190):185-201. PubMed ID: 19096778
[TBL] [Abstract][Full Text] [Related]
3. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to aquaporins are frequent in patients with primary Sjögren's syndrome.
Tzartos JS; Stergiou C; Daoussis D; Zisimopoulou P; Andonopoulos AP; Zolota V; Tzartos SJ
Rheumatology (Oxford); 2017 Dec; 56(12):2114-2122. PubMed ID: 28968830
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and diagnosis of Sjögren's syndrome].
Witte T
Z Rheumatol; 2010 Feb; 69(1):50-6. PubMed ID: 20012975
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
[TBL] [Abstract][Full Text] [Related]
7. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
8. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
9. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.
Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients.
Verbaan H; Carlson J; Eriksson S; Larsson A; Liedholm R; Manthorpe R; Tabery H; Widell A; Lindgren S
J Intern Med; 1999 Feb; 245(2):127-32. PubMed ID: 10081515
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
13. Immunohistopathology of Sjögren's syndrome.
Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
16. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
17. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
19. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
20. A role for lymphotoxin in primary Sjogren's disease.
Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
